Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Diseases (2)
- Life Sciences (2)
- Nucleic Acids, Nucleotides, and Nucleosides (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Biochemistry (1)
-
- Biochemistry, Biophysics, and Structural Biology (1)
- Biological Factors (1)
- Cancer Biology (1)
- Cell and Developmental Biology (1)
- Chemistry (1)
- Comparative and Laboratory Animal Medicine (1)
- Genetic Processes (1)
- Immunology and Infectious Disease (1)
- Laboratory and Basic Science Research (1)
- Male Urogenital Diseases (1)
- Medical Cell Biology (1)
- Medical Genetics (1)
- Medical Molecular Biology (1)
- Medical Sciences (1)
- Medical Specialties (1)
- Natural Products Chemistry and Pharmacognosy (1)
- Organisms (1)
- Other Chemicals and Drugs (1)
- Other Immunology and Infectious Disease (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Physical Sciences and Mathematics (1)
- Therapeutics (1)
- Translational Medical Research (1)
- Institution
Articles 1 - 3 of 3
Full-Text Articles in Chemicals and Drugs
Fluorescently Labeled Sirnas And Their Theranostic Applications In Cancer Gene Therapy, Stephen David Kozuch
Fluorescently Labeled Sirnas And Their Theranostic Applications In Cancer Gene Therapy, Stephen David Kozuch
Seton Hall University Dissertations and Theses (ETDs)
Gene therapy has emerged as a promising precision nano-medicine strategy in the treatment of numerous diseases including cancer. At the forefront of its utility are the applications of short-interfering RNA (siRNA), that silence oncogenic mRNA expression leading to cancer cell death through the RNA interference (RNAi) pathway. Despite the therapeutic potential, siRNAs are limited by poor pharmacological properties, which has hindered their translation into the clinic. Recent studies, however, have highlighted the applications of modified siRNAs, including the use of fluorescent probes and siRNA nanostructures in cancer detection and treatment. The siRNAs reported in this thesis are designed to target …
Paclitaxel Enhances Oncolytic Potential Of Herpes Simplex Virus Type-1 In Cancer Cells, Misagh Naderi
Paclitaxel Enhances Oncolytic Potential Of Herpes Simplex Virus Type-1 In Cancer Cells, Misagh Naderi
LSU Master's Theses
Taxanes are spindle poisons that bind to and stabilize microtubules resulting in mitotic arrest. Herpes simplex Typ-1 (HSV-1) virions utilize the microtubular network for intracellular transport during both virus entry and virus egress from infected cells. It has been reported previously that taxanes may synergize with oncolytic herpes simplex viruses in the treatment of experimental prostate and breast tumors in mice. Other reports have indicated that taxanes may inhibit viral replication in infected cells. In this study the previously characterized Oncolytic Herpes Simplex Virus type 1 (OSVP), which was constructed in Kousoulas lab was used in conjugation with paclitaxel (taxol) …
Microrna 1207-3p In Prostate Cancer, Dibash Das
Microrna 1207-3p In Prostate Cancer, Dibash Das
Dissertations, Theses, and Capstone Projects
Prostate cancer (PCa) is the most commonly diagnosed male cancer and the second leading cause of cancer-related death for men in the United States. Understanding the molecular mechanisms involved in progression from the asymptomatic androgen-dependent PCa to the lethal castration resistant prostate cancer (CRPC) is a major challenge. MicroRNAs (miRNAs), are known to be dysregulated in PCa. MicroRNA-1207-3p (miR-1207-3p) is encoded by the non-protein coding gene locus PVT1 on the 8q24 human chromosomal region, an established PCa susceptibility locus. However, the role of miR-1207-3p in PCa is unclear. We have discovered that miR-1207-3p is significantly underexpressed in PCa cell lines …